Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03575013
Title A Combination of Avelumab and Taxane (AVETAX) for Urothelial Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Rohan Garje

urethra transitional cell carcinoma

ureter transitional cell carcinoma

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma


Avelumab + Docetaxel

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.